相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways
Md Zahidul I. Pranjol et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer
Muhammad Tariq et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
Pablo Scodeller et al.
SCIENTIFIC REPORTS (2017)
Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers
Hasitha Shilpa Anantaraju et al.
MOLECULAR DIVERSITY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
Falk Nimmerjahn et al.
TRENDS IN IMMUNOLOGY (2015)
Unraveling the molecular architecture of a G protein-coupled receptor/β-arrestin/Erk module complex
Thomas Bourquard et al.
SCIENTIFIC REPORTS (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer
Haidar Saadoun et al.
FUTURE ONCOLOGY (2014)
Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse
Stanislas du Manoir et al.
MOLECULAR ONCOLOGY (2014)
Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment
Marie Maynadier et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies
Dmitrij Hristodorov et al.
MOLECULAR BIOTECHNOLOGY (2013)
A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
Liang Huang et al.
PLOS ONE (2013)
Current advances in humanized mouse models
Ryoji Ito et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment
Valerie Laurent-Matha et al.
FASEB JOURNAL (2012)
Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis
D. Derocq et al.
ONCOGENE (2012)
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Jonas Fuxe et al.
SEMINARS IN CANCER BIOLOGY (2012)
Interleukin-15 biology and its therapeutic implications in cancer
Jason C. Steel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies
Andrei Turtoi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
Olivier Masson et al.
BIOCHIMIE (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth
Melanie Beaujouin et al.
JOURNAL OF CELL SCIENCE (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cathepsin D-Many functions of one aspartic protease
Petr Benes et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm
Pascal Philibert et al.
BMC BIOTECHNOLOGY (2007)
Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing
Lara Hasan et al.
JOURNAL OF IMMUNOLOGY (2006)
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
Eija Siintola et al.
BRAIN (2006)
Catalytically inactive human cathepsin D triggers fibroblast invasive growth
V Laurent-Matha et al.
JOURNAL OF CELL BIOLOGY (2005)
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-la, macrophage inflammatory protein-1β, and SLC that are expressed in human breast cancer
M Wolf et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors
V Vetvicka et al.
CANCER GENE THERAPY (2002)
Cathepsin-D affects multiple tumor progression steps in vivo:: proliferation, angiogenesis and apoptosis
G Berchem et al.
ONCOGENE (2002)
Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells
M Glondu et al.
ONCOGENE (2002)
分享论文
